01457nam a2200193 a 450000100080000000500110000800800410001902200140006002400380007410000140011224501310012626001420025750003900039952003380078965300480112765300560117570000150123170000170124610642992023-08-18       2023    bl uuuu     u01u1 u    #d  a2772-283X7 a10.1016/j.anscip.2023.03.0912DOI1 aKMAID, S.  a090. Pregnancy rate after tolfenamic acid treatment in bovine embryo recipients. [conference abstract].h[electronic resource]  aAnimal - science proceedings, May 2023, Volume 14, Issue 3, Page 487. https://doi.org/10.1016/j.anscip.2023.03.091  -- OPEN ACCESS.c2023  aArticle history: Available online 5 June 2023, Version of Record 5 June 2023. -- Corresponding author: Sergio Kmaid. E-mail: skmaid@gmail.com --  Part of special issue: 11th International Ruminant Reproduction Symposium (IRRS 2023). 28 May-1 June 2023, Galway, Ireland. Publication supported by IRRS (https://www.sciencedirect.com/journal/animal-science-proceedings/vol/14/issue/3 ) --  aApplication: Assessment of a nonsteroidal anti-inflammatory drug (NSAID) treatment at embryo transfer in recipient cows. Introduction: Reproductive tract manipulation in recipient cows may induce endometrial prostaglandin release causing luteolysis and decreased progesterone levels, potentially contributing to early embryonic loss.  aNonsteroidal anti-inflammatory drug (NSAID)  aPLATAFORMA DE INVESTIGACIÓN EN SALUD ANIMAL - INIA1 aRENAUD, P.1 aMENCHACA, A.